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Abstract
AIM
To investigate the intestinal segment-specific effects 
of diabetes and insulin replacement on the density of 
different subpopulations of submucous neurons. 
METHODS
Ten weeks after the onset of type 1 diabetes samples 
were taken from the duodenum, ileum and colon of 
streptozotocin-induce diabetic, insulin-treated diabetic 
and sex- and age-matched control rats. Whole-mount 
preparations of submucous plexus were prepared 
from the different gut segments for quantitative fluore-
scent immunohistochemistry. The following double-
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immunostainings were performed: neuronal nitric oxide 
synthase (nNOS) and HuC/D, heme oxygenase (HO) 
1 and peripherin, as well as HO2 and peripherin. The 
density of nNOS-, HO1- and HO2-immunoreactive (IR) 
neurons was determined as a percentage of the total 
number of submucous neurons.   
RESULTS
The total number of submucous neurons and the pro-
portion of nNOS-, HO1- and HO2-IR subpopulations 
were not affected in the duodenal ganglia of control, 
diabetic and insulin-treated rats. While the total 
neuronal number did not change in either the ileum 
or the colon, the density of nitrergic neurons exhibited 
a 2- and 3-fold increase in the diabetic ileum and 
colon, respectively, which was further enhanced after 
insulin replacement. The presence of HO1- and HO2-IR 
submucous neurons was robust in the colon of controls 
(38.4%-50.8%), whereas it was significantly lower in 
the small intestinal segments (0.0%-4.2%, P  < 0.0001). 
Under pathophysiological conditions the only alteration 
detected was an increase in the ileum and a decrease 
in the colon of the proportion of HO-IR neurons in 
insulin-treated diabetic animals.   
CONCLUSION
Diabetes and immediate insulin replacement induce the 
most pronounced region-specific alterations of nNOS-, 
HO1- and HO2-IR submucous neuronal density in the 
distal parts of the gut. 
Key words: Nitrergic neurons; Heme oxygenase 1; 
Heme oxygenase 2; Submucous neurons; Gut region-
specificity; Diabetes; Insulin
© The Author(s) 2017. Published by Baishideng Publishing 
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Core tip: Our present findings demonstrate for the first 
time the segment–specific alterations of the proportion 
of nitrergic, heme oxygenase (HO)1-immunoreactive 
(IR) and HO2-IR neurons in the submucous plexus of 
control, diabetic and insulin-treated diabetic rats. Our 
results suggest that duodenal nitrergic neurons are 
not affected, but ileal and colonic ones are induced to 
change their neurochemical character in diabetes and 
insulin replacement. The colonic ganglia are abundant 
in HO-IR neurons in both controls and diabetics, 
whereas insulin treatment decreases their proportion. 
In contrast to the colon, the low amount of HO-IR ileal 
neurons was increased by insulin-treatment.
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INTRODUCTION
Diabetes has widespread effects on gastrointestinal 
(GI) function causing different GI symptoms, including 
nausea, vomiting, abdominal pain, constipation or 
diarrhoea[1]. The functional impairments of the GI 
tract in diabetes are studied intensively; however, 
the complexity of diabetes-related pathophysiological 
consequences hinders the attainment of clear findings 
about the underlying mechanisms and alterations. An 
increasing body of evidence confirms that the impaired 
function of the enteric nervous system (ENS) is closely 
related to the GI syndromes of diabetic patients[2-4]. 
The ENS is an autonomous entity structured as two 
major ganglionated plexi, i.e., the myenteric and the 
submucosal plexi. The myenteric plexus regulates 
intestinal motility[5]. It is more difficult to determine the 
functions of submucous neurons because of differences 
in the organization and function of the submucous 
plexus: it is more complex in large mammals with at 
least two distinct nerve networks than in small rodents. 
Submucous neurons regulate electrolyte absorption 
across the mucosa, blood flow and mucosal secretion 
in small rodents[6,7], moreover in large mammals it is 
involved both in mucosal and motility processes[8,9]. 
The alterations in the number of inhibitory neurons 
including nitrergic neurons in diabetes and their 
responsiveness to insulin treatment have been inten-
sively studied, but these investigations mainly target 
the myenteric plexus. Furthermore, a region-specific 
susceptibility of the nitrergic neurons to diabetes- as 
well as insulin-related damages was identified in the 
myenteric plexus[10-12].   
In contrast to the intense interest in the neuro-
chemical characterization of myenteric neurons in 
non-diabetic and diabetic state, the submucous 
plexus is poorly investigated in diabetes. A decreased 
total and an unchanged nitrergic submucous neur-
onal density were found in the jejunum and ileum in 
streptozotocin-induced (STZ) diabetes as compared to 
the controls[13,14], but we have no information about the 
effects of insulin treatment on the submucous neurons.
Long-lasting hyperglycemia can lead to oxidative 
stress, an imbalance between the increased production 
of reactive oxygen and nitrogen species (RONS) and 
the decrease of antioxidant defence mechanisms, 
which have been implicated in the damage of the ENS 
such as quantitative and neurochemical changes of the 
enteric neurons. The systemic oxidative state in type 
2 diabetic patients was proved by the determination 
of serum oxidative stress markers including increased 
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malondialdehyde level and superoxide dismutase 
activity, decreased glutathione reductase, glutathione 
peroxidase, glucose-6-phosphate dehydrogenase 
enzyme activities and glutathione level[15]. This 
oxidative state was further confirmed by the results 
from diabetic duodenum and colon of human patients 
or rats, where it led to the apoptosis of enteric neurons 
and to neuronal remodelling in the ENS[16,17].   
The heme catabolizing heme oxygenase (HO) 
enzyme plays an essential role in antioxidant defence 
mechanisms. This enzyme has two main isoforms 
including the inducible HO1 and the constitutive HO2. 
Of the two, HO2 is described as the isoform widely 
expressed in the neuronal and non-neuronal cell types 
of the healthy GI tract, and both HO1 and HO2 can 
be co-localized with neuronal nitric oxide synthase 
(nNOS)[18-21]. In diabetic rat ileum, the nitrergic 
myenteric neurons containing HO2 were more resistant 
to the effect of experimentally induced diabetes on cell 
body size[22]. However, the detailed characterization 
of the changes of HO1-immunoreactive (HO1-IR) 
and HO2-IR submucous neurons in the different gut 
regions of diabetic and insulin-treated diabetic rats has 
not been accomplished.
In view of the interest in understanding the gut 
segment-dependent changes in the submucous plexus 
in diabetes and insulin-treated diabetes, our study 
aimed to reveal the region-specific alterations in the 
density of neurons containing nNOS as well as HO1 or 
HO2 enzymes in the different segments of the small 
and large intestine of control, diabetic and insulin-
treated diabetic rats. 
MATERIALS AND METHODS
Animal model
Adult male Wistar rats (Crl:WI BR; Toxi-Coop Zrt.) 
weighing 210–260 g, kept on standard laboratory 
chow (Farmer-Mix Kft., Zsámbék) and with free 
access to drinking water were used throughout the 
experiments. The rats were divided randomly into 
three groups: STZ-induced diabetics (diabetics; 
n = 6), insulin-treated STZ-induced diabetics 
(insulin-treated diabetics; n = 4) and sex- and age-
matched controls (n = 5). Hyperglycaemia was 
induced as described previously[10,23]. The animals 
were considered diabetic if the non-fasting blood 
glucose concentration was 18 mmol/L. From this 
time on, one group of hyperglycaemic rats received 
a subcutaneous injection of insulin (Humulin M3, Eli 
Lilly Nederland) each morning (2 IU) and afternoon (2 
IU). The blood glucose level and weight of each animal 
were measured weekly. In all procedures involving 
experimental animals, the principles of laboratory 
animal care (NIH Publication No. 85-23, revised 1985) 
were strictly followed, and all the experiments were 
approved in advance by the Local Ethics Committee for 
Animal Research Studies at the University of Szeged.
Tissue handling
Ten weeks after the onset of diabetes, the animals 
were killed by cervical dislocation under chloral hydrate 
anaesthesia (375 mg/kg i.p.). The gut segments of 
control, diabetic and insulin-treated diabetic rats were 
dissected and rinsed in 0.05 mol/L phosphate buffer 
(PB, pH 7.4). Samples were taken from the duodenum 
(1 cm distal to the pylorus), the ileum (1 cm proximal 
to the ileocecal junction), and the proximal colon 
and processed for immunohistochemical studies. For 
double-labelling fluorescent immunohistochemistry, 
the intestinal segments were cut along the mesentery, 
pinched flat and fixed overnight at 4 ℃ in 4% 
paraformaldehyde solution buffered with 0.1 mol/L 
PB (pH 7.4). The samples were then washed, and to 
obtain the whole-mounts of the submucous plexus, 
the muscular layers of the gut wall were removed, and 
the mucosa was extracted by scrapping with a small 
spatula under an Olympus SD30 stereomicroscope. 
Double-labelling fluorescent immunohistochemistry
For quantitative immunohistochemistry, whole-mount 
preparations derived from different gut segments were 
double-immunostained with nNOS and HuC/D, HO1 
and peripherin, as well as HO2 and peripherin. Briefly, 
after blocking the preparations in PB containing 0.1% 
bovine serum albumin, 10% normal goat serum and 
0.3% Triton X-100, they were incubated overnight 
with anti-nNOS (rabbit; Cayman Chemical, Ann Arbor, 
MI, the United States of America; final dilution 1:200) 
in combination with anti-HuC/D (mouse; Molecular 
Probes, Eugene, OR, the United States of America; final 
dilution 1:50), anti-HO1 (mouse; Novus Biologicals 
Europe, Abington, United Kingdom; final dilution 1:200) 
or anti-HO2 (mouse; Santa Cruz Biotechnology, Inc., 
Dallas, TX, the United States of America; final dilution 
1:50) in combination with anti-peripherin (rabbit; 
Millipore, Temecula, CA, the United States of America; 
final dilution 1:400) primary antibodies. After washing 
in PB, whole-mounts were incubated with anti-rabbit 
Alexa Fluor 488 (Life Technologies Corporation, 
Molecular Probes, Inc., Eugene, OR, the United States 
of America; final dilution 1:200) and anti-mouse 
CyTM3 (Jackson ImmunoResearch Laboratories, Inc., 
Baltimore Pike, PA, the United States of America; 
final dilution 1:200) secondary antibodies for 4 h. All 
incubations were carried out at room temperature. 
Negative controls were performed by omitting the 
primary antibody, when no immunoreactivity was 
observed. Whole-mounts were mounted on slides in 
EverBriteTM Mounting Medium (Biotium, Inc., Hayward, 
CA, the United States of America), observed and 
photographed with an Olympus BX51 fluorescent 
microscope equipped with an Olympus DP70 camera. 
One hundred submucous ganglia were taken from 
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total submucous neuronal number, nNOS and HuC/D 
double-labelling fluorescent immunohistochemistry 
was applied, as shown in the representative 
micrograph (Figure 1). In the total number of neurons, 
no changes were found between the different gut 
segments within the control group or among the three 
experimental groups in the duodenal, ileal or colonic 
intestinal regions (data are not shown). The proportion 
of nitrergic neurons in the total neuronal number 
did not show any differences between the three 
investigated gut segments of controls (Figure 2A). STZ 
treatment resulted in an increase in the proportion of 
nitrergic neurons in the distal intestinal segments (in 
the ileum and colon) but not in the duodenum. The 
proportion of the nitrergic subpopulation exhibited a 
2-fold increase in the ileum (12% vs 6% in controls), 
whereas a 3-fold increase was observed in the colon 
of diabetics (22% vs 8% in controls; Figure 2B). The 
insulin treatment had no effect on the proportion of 
duodenal and colonic nitrergic submucous neurons 
which, however, was found to increase significantly in 
the ileal segment as compared to the diabetic rats. 
Proportion of HO1-IR neurons
To visualize and quantify the occurrence of HO1-IR 
submucous neurons, HO1 immunohistochemistry 
was used combined with peripherin as pan-neuronal 
marker (Figure 3).
The distribution of HO1-IR submucous neurons 
as compared to total neuronal number demonstrated 
region-dependent differences in the three examined 
segments even in the controls. The proportion of 
duodenal and ileal HO1-IR submucous neurons was 
only 4% and 0%, respectively, but the occurrence of 
HO1-IR neurons was extremely robust in the colon 
(51%; P < 0.0001; Figure 4A). In the diabetics, 
results similar to the controls were obtained along the 
intestinal tract, with HO1-IR neurons seldom occurring 
in the small intestine and present in abundance in the 
large intestine (Figure 4B). In the duodenal segment 
no change was induced by the insulin treatment in 
the presence of HO1-IR neurons, whereas in the 
ileum quantitative analysis of the HO1-IR submucous 
subpopulation revealed a significant increase in the 
proportion of these neurons in the insulin-treated 
diabetic group (6%) as compared to the control group 
(0%). In the colonic submucous ganglia we found a 
significant decrease in the insulin-treated diabetics 
each intestinal segment in each experimental group 
and we counted the nNOS-, HO1- and HO2-IR neurons 
and the HuC/D- and peripherin-IR neurons to yield the 
total number of submucous neurons. We determined 
the nNOS-, HO1- and HO2-IR neurons as a percentage 
of the total number of neurons.
Statistical analysis
Statistical analysis was performed with one-way 
ANOVA and the Newman–Keuls test. All analyses 
were carried out with GraphPad Prism 6.0 (GraphPad 
Software, La Jolla, CA, the United States of America). 
A probability of P < 0.05 was set as the level of 
significance. All data were expressed as mean ± SE.
RESULTS
Pathophysiological characteristics of diabetes
According to the data shown in Table 1, STZ promoted 
hyperglycaemia in the diabetic rats (23.31 ± 0.53 
mmol/L), but the insulin treatment prevented the 
extremely high blood glucose concentration (9.48 ± 
0.14 mmol/L). The weight of the animals significantly 
increased in all groups during the ten weeks of the 
experiment, but the final body weight of diabetic rats 
was less elevated compared to the control and the 
insulin-treated diabetic animals. 
Proportion of nNOS-IR neurons
To determine the proportion of nNOS-IR neurons in the 
Figure 1  Representative fluorescent micrograph of a whole-mount 
preparation of submucous ganglia from the colon of a diabetic rat after 
nNOS-HuC/D double-labelling immunohistochemistry. Red arrows indicate 
neurons labelled for HuC/D only, blue arrows show neurons double-labelled for 
both nNOS and HuC/D; Scale bar: 50 μm.
Table 1  Weight and glycaemic characteristics of the three experimental groups of rats
Weight (g) Blood glucose level (mmol/L)
Initial Final Initial Average
Controls (n = 5) 232.2 ± 7.29 486 ± 4.93a 7.08 ± 0.22 6.3 ± 0.13
Diabetics (n = 6) 235.3 ± 10.48 382.7 ± 3.53a,b 6.6 ± 0.1 23.31 ± 0.53a,b
Insulin-treated diabetics (n = 4) 251.5 ± 4.35 481.5 ± 13.4a,c 6.65 ± 0.18 9.48 ± 0.14a,b,c
Data are expressed as mean ± SE; aP < 0.0001 vs initial, bP < 0.0001 vs final controls, and cP < 0.0001 vs final diabetics.
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(14%) as compared to the control (51%) or the 
diabetic (38%) groups (Figure 4B).   
Proportion of HO2-IR neurons 
The occurrence of HO2-IR submucous neurons was 
also calculated as the proportion of peripherin-stained 
total submucous neuronal number (Figure 5). In 
the controls, the HO2-IR neurons demonstrated a 
distribution similar to that of the HO1-IR submucous 
neurons. In the segments of small intestine, a low 
level of HO2-IR neurons was detected (4% in the 
duodenum, 1% in the ileum), but in the colon this 
proportion was significantly higher (38%; P < 0.0001; 
Figure 6A). In the diabetics, results similar to the 
controls were obtained along the intestine; the marked 
differences in the ratio of HO2-IR neurons between the 
different gut segments remained unchanged (Figure 6B).
Immediate insulin replacement had no effect on 
the abundance of HO2-IR neurons in the duodenum. 
Although the ileal segment showed the lowest 
proportion of HO2-IR neurons compared to the 
other two control regions, a significant increase in 
their numbers was found in the ileum after insulin 
replacement (17%) compared to the control (1%) and 
the diabetic rats (6%). The proportion of colonic HO2-
IR neurons showed a pattern similar to that of the 
HO1-IR neurons in the same segment. The ten-week 
insulin treatment reduced the proportion of HO2-IR 
neurons (28%) below control level, and this decrease 
was significant as compared to the diabetic group 
(52%; Figure 6B).
DISCUSSION
In the present study we investigated the nitrer-
gic subpopulation of submucous neurons similarly 
to our earlier study on the myenteric plexus. In 
that study we published the gut region-dependent 
quantitative changes of the total population and 
the nitrergic subpopulation of myenteric neurons in 
STZ-induced diabetic and insulin-treated diabetic 
rats[10]. In the present study we demonstrate that 
the total submucous neuronal number is similar in 
the duodenum, ileum and colon in the controls, and 
remains unchanged in diabetes as well as after insulin 
replacement. This is in agreement with the observation 
of da Silva et al[24], however their investigations are 
limited to the ileum. Our data reflect that STZ-induced 
diabetes does not induce degenerative changes in the 
total population of submucous neurons, unlike our 
previous data about the myenteric plexus. Oxidative 
stress is known to be induced by hyperglycaemia 
in diabetes via the mitochondrial overproduction of 
RONS, which leads to an imbalance between free 
radical production and antioxidant defense molecules 
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Figure 2  Proportion of nitric oxide synthase-immunoreactive neurons related to the total number of submucous neurons in the duodenum, ileum and 
colon. A: Only in controls; B: in control, diabetic and insulin-treated diabetic rats. Data are expressed as mean ± SE; aP < 0.05 and eP < 0.0001 vs controls, cP < 0.05 
vs diabetics. IR: Immunoreactive; C: Controls; D: Diabetics; ID: Insulin-treated diabetics.
Figure 3  Representative fluorescent micrograph of a whole-mount prepar-
ation of submucous ganglia from the colon of a control rat after HO1-
peripherin double-labelling immunohistochemistry. Red arrows indicate 
neurons labelled for peripherin only, blue arrows show neurons double-labelled 
for both HO1 and peripherin; Scale bar: 50 μm.
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or mechanisms[15-17]. We suggest, in accordance with 
the opinion of Lopes et al[13], that submucous neurons 
may have greater resistance to RONS under diabetic 
conditions.
In non-diabetic state, nitrergic myenteric and 
submucous neurons have been examined along 
the gut in different rodent species, and it has been 
described that the myenteric plexus has more nitrergic 
neurons as compared to the submucous plexus[25-27]. 
Using the same rat model of type 1 diabetes as Izbéki 
et al[10], the gut segment-specific alterations in the 
two ganglionated plexi can be compared. According 
to the investigation of the myenteric plexus in the 
controls, the ileum contained the lowest proportion of 
nitrergic neurons[10], but we found no region-specific 
differences in the submucous plexus in accordance 
with other findings[28,29]. We have revealed different 
effects of hyperglycaemia on the ratio of nitrergic 
neurons in the two plexi; a significant decrease was 
seen in all segments of the myenteric plexus, but, with 
the exception of the duodenum, an increase was found 
in the ileal and colonic submucous ganglia. Our results 
demonstrate that not only total neuronal density but 
also the nitrergic subpopulation of the two plexi are 
affected in a different way by the diabetic state. 
Because of the unchanged total neuronal number 
in submucous ganglia, alterations of the neurochemical 
character as an adaptation to diabetes-related oxidative 
stress is suggested to be in the background of these 
modifications. Neurochemical changes as an answer 
of the ENS to pathological conditions including Crohn’
s disease, ulcerative colitis or Parkinson’s disease are 
known[30-32]. Moreover, there is evidence that diabetic 
neuropathy and changes in neurochemical coding 
can occur in the submucous plexus of the ENS[13,14]. 
We found a similar result in another pathological rat 
model, in chronic ethanol-consumption, where the total 
myenteric neuronal number remained constant, but the 
density of nitrergic neurons was changed[33,34]. Previous 
studies showed that there are few nitrergic neurons in 
the submucous ganglia, the submucous plexus is more 
abundant in vasoactive intestinal polypeptide (VIP)-
IR neurons as compared to the myenteric plexus, and 
there is a high proportion of VIP and nNOS co-localizing 
neurons in both plexi[14,35]. Lin et al[36] demonstrated 
that colonic VIP-IR submucous neurons start to express 
nNOS during culturing as a form of functional plasticity. 
Our results reported here show gut segment-
specific alterations of not only the nitrergic, but also 
the HO1-IR and HO2-IR submucous neurons, and 
these alterations become increasingly pronounced 
along the proximo-distal axis of the gut. An important 
finding of this study is that HO1-IR and HO2-IR 
neurons are more abundant in the colon (about half 
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Figure 4  Proportion of HO1-immunoreactive neurons related to the total number of submucous neurons in the duodenum, ileum and colon. A: Only in 
controls; B: In control, diabetic and insulin-treated diabetic rats. Data are expressed as mean ± SE; fP < 0.0001 vs control duodenum; gP < 0.0001 vs control ileum, aP 
< 0.05 and eP < 0.0001 vs controls, and dP < 0.01 vs diabetics. IR: Immunoreactive; C: Controls; D: Diabetics; ID: Insulin-treated diabetics.
Figure 5  Representative fluorescent micrograph of a whole-mount 
preparation of submucous ganglia from the colon of a control rat after 
HO2-peripherin double-labelling immunohistochemistry. Red arrows 
indicate neurons labelled for peripherin only, blue arrows show neurons double-
labelled for both HO2 and peripherin; Scale bar: 50 μm.
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of the colonic neurons was HO-IR) than in the small 
intestinal segments (about 0%-5%) in the controls, 
and STZ treatment did not result in any significant 
changes in the investigated regions. The question 
arises as to what the reasons underlying these 
differences are. In non-diabetic state, more RONS are 
generated in the colon then in the small intestine[37]. 
It is possible that under worsening oxidative 
circumstances the pro-oxidant basal state in the colon 
acts as a preconditioning factor inducing the higher 
physiological activity of both isoforms of the antioxidant 
HO enzymes. This mechanism may play a role in the 
protection of this segment against neuronal cell loss 
regarding the total submucous neuronal number in 
diabetic condition, in contrast to earlier findings in the 
colonic myenteric ganglia. The neuroprotective, anti-
apoptotic effects of the HO1 enzyme in oxidative stress 
were proved in the central ENS[38,39]. However, we did 
not investigate the co-localization of nNOS with HO in 
these neurons, despite earlier findings demonstrating 
the beneficial effects of the coexistence of these 
enzymes on the myenteric neurons[22]. Moreover, 
former studies visualized nNOS-HO2-IR neurons in the 
submucous ganglia[19,20,40], which suggests a protective 
role of HO, and may contribute to our results revealing 
the increasing proportion of nitrergic neurons in the 
diabetic ileum and colon.     
The data about the effects of insulin are contra-
dictory. While early insulin replacement was preventive 
to the total population of colonic myenteric neurons[10], 
we found no changes in the three intestinal regions 
in the total number of submucous neurons of insulin-
treated diabetic rats. The density of nitrergic neurons 
showed similar patterns in the two plexi after insulin 
replacement, an increase was found from proximal to 
distal direction, which means significant changes in the 
ileum and the colon as compared to untreated diabetic 
rats. 
As in the case of the nitrergic subpopulation, not 
the duodenal, but the ileal and colonic HO1- and HO2-
IR submucous neurons responded to insulin treatment, 
but in an opposite way. However, there were no 
differences between the control and diabetic groups in 
these two regions and we found an increased density 
in the ileum, but a decreased abundance in the colon 
of insulin-treated diabetic rats.   
Our results suggest that the three investigated gut 
segments have different levels of responsiveness to 
immediate insulin replacement in diabetes regarding 
the nitrergic and HO-IR subpopulation of submucous 
neurons. This is confirmed by our earlier findings in 
the myenteric neurons and in their microenvironment 
including the capillary endothelium adjacent to the 
myenteric ganglia[23]. The environmental changes 
of submucous ganglia were described, such as the 
alteration of the faeces-associated microbiota in 
diabetes and insulin-treatment[41]. Moreover, microangi-
opathy as a complication of diabetes in submucosal 
vessels of the GI tract was identified on duodenal and 
colon samples from diabetic patients[42,43]. On the other 
hand, our results are in accordance with the previous 
contradictory data about the beneficial or harmful 
effects of insulin. Insulin was shown to induce DNA 
damage through the enhanced production of RONS and 
to increase the risk of cancer in different cell types[44,45]. 
But insulin therapy decreased vascular superoxide 
overproduction in diabetic rats generated by NADPH 
oxidase, NOS or xanthine oxidase[46]. It is important to 
mention that the nitric oxide produced by NOS and the 
carbon monoxide generated by HO enzymes may have 
either pro-oxidant or antioxidant effects depending on 
the microenvironment, the duration of production and 
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the amount of these gases[47-49].  
This complex background makes it difficult to 
understand the details of our recent findings, and 
further experiments are needed to explore the 
mechanisms of physiological and pathological events 
in the submucous neurons in diabetes and insulin 
replacement, their relationships and communication 
with their environment.    
In summary, our present study provides evidence 
for the first time that the neurochemical character of 
the nitrergic submucous neurons exhibits gut region-
dependent changes in diabetic and insulin-treated 
diabetic rats. In addition, we prove that HO1-IR and 
HO2-IR submucous neurons are present in small 
amounts in the small intestine, but in high abundance 
in the colon of control and diabetic rats, and they have 
segment-specific responsiveness to immediate insulin 
replacement.
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